Changes in Eye Shape With Myopia Management Interventions
Key facts
- Who runs it
- Ohio State University
- Where
- Columbus, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 75 people enrolled
- Started
- 1 Aug 2024
- Ended
- 4 Sept 2026
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Atropine Ophthalmic
- MiSight 1-day disposable contact lenses
- Record updated
- 5 November 2026
Who can take part
- Age
- 21 years to 30 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- best corrected visual acuity of 20/25 or better in each eye
- nearsighted
- current contact lens wearer
- normal binocular vision (to be determined by an examiner at the first study visit)
Who cannot take part
- eye diseases (including lazy eye or eye turn)
- history of refractive surgery (e.g., LASIK)
- history of myopia control treatment
- pregnant, nursing, or planning a pregnancy in the next 12 months
- sensitivity to anesthetics or preservative in eye drops
- difficulty with pupillary dilation
Where in United States
- The Ohio State UniversityColumbus, United States
About the trial
What the trial wants to find out
The goal of this clinical trial is to study changes in eye shape of nearsighted young adults using low-dose atropine eye drops or soft multifocal contact lenses. The main questions it aims to answer are:
Read full original descriptionShow less
* do low-dose atropine and soft multifocal contact lenses affect the shape of the peripheral eye? * are changes in peripheral eye shape from these interventions influenced by changes in the focusing system of the eye?
Participants will:
* have multiple different types of photos taken * have their prescription for glasses/contacts checked * have their eye health checked, including the use of dilating eye drops * be randomly assigned to use eye drops every night or wear special contact lenses daily instead of their typical contacts * will complete five study visits over the course of 12 months
Researchers will compare young adults using low-dose atropine to those wearing soft multifocal contact lenses and to those using no intervention to see if using these interventions affects retinal shape.
The 3 groups in the trial
- ObservationNo study treatment, for comparison
Participants randomized to the observation arm will receive no intervention.
- Low-dose atropineTreatment being tested
Participants randomized to low-dose atropine will instill one drop of 0.05% atropine in each eye at bedtime for 12 months.
Treatment: Atropine Ophthalmic
- Soft multifocal contact lensesTreatment being tested
Participants randomized to soft multifocal contact lenses will wear MiSight 1-day disposable contact lenses for 5-7 days per week for 12 months.
Treatment: MiSight 1-day disposable contact lenses
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Longitudinal Changes in Eye Shape in Young Adults Treated With Low-Dose Atropine and Soft Multifocal Contact Lenses
- Record updated
- 5 November 2026